NCT00060632 2015-08-27
Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 1 Completed
Clinical Trials
3 trialsNCT00060645 2015-08-27
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00086125 2015-08-19
Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 2 Completed